Management and prediction of immune-related adverse events for PD1/PDL-1 immunotherapy in colorectal cancer

Programmed cell death protein (PD-1) is an important immunosuppressive molecule, which can inhibit interaction between PD-1 and its ligand PD-L1, further enhancing the T cell response and anti-tumor activity, which is called immune checkpoint blockade. Immunotherapy, represented by immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Liting, Meng, Cong, Zhang, Xiao, Gao, Jiale, Wei, Pengyu, Zhang, Jie, Zhang, Zhongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176603/
https://www.ncbi.nlm.nih.gov/pubmed/37188271
http://dx.doi.org/10.3389/fphar.2023.1167670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176603/
https://www.ncbi.nlm.nih.gov/pubmed/37188271
http://dx.doi.org/10.3389/fphar.2023.1167670

Ejemplares similares